IP Verse

Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of Osteoporosis

Patent No. EP3071206 (titled "Gastrin Antagonists (Eg Yf476, Netazepide) For Treatment And Prevention Of Osteoporosis") was filed by CL Biosciences on Nov 21, 2014. The application was issued on Feb 17, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TRIO MEDICINESNov 17, 2021HARRIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3071206

CL BIOSCIENCES
Application Number
EP14815149A
Filing Date
Nov 21, 2014
Status
Granted And Under Opposition
Jan 15, 2021
Publication Date
Feb 17, 2021
External Links
Slate, Register , Google Patents